Marcelo G. Davanço is a PhD in Health Sciences (Pharmacology) and a Master’s in Pharmaceutical Sciences (Pharmacokinetics). He has experience in pharmacokinetics, bioequivalence, in vitro–in vivo correlation (IVIVC), drug interaction studies, and bioanalytical method development. He has published scientific articles in key areas of drug development and is the author of the book "In Vitro–In Vivo Correlation in Drug Development” (Appris, 2023). He is a a member of the Brazilian Academy of Pharmaceutical Sciences and, currently, serves as Head of Bioequivalence at Knight Therapeutics.